Results 101 to 110 of about 288,852 (258)
Aim: It was aimed to compare the outcomes of sleeve lobectomy with video-assisted thoracoscopic surgery (VATS) and thoracotomy in patients with centrally located non-small cell lung cancer (NSCLC).
Ece Yasemin DEMİRKOL +7 more
doaj +1 more source
State-of-the-art MR Imaging for Thoracic Diseases. [PDF]
Tanaka Y +13 more
europepmc +1 more source
ZDHHC17 palmitoylates CDK4, which together with TRAF6‐mediated ubiquitination, drives cell cycle progression and immune surveillance, revealing a rational combination of CDK4 inhibitors with immune checkpoint blockers for ZDHHC17‐driven cancers. ABSTRACT Uncontrolled cell cycle progression is a hallmark of cancer, tightly regulated by both intrinsic ...
Zekang Wang +7 more
wiley +1 more source
Editorial: Novel Insight Into the Diagnosis and Treatment of Cardio(Thoracic) Diseases in Dogs and Cats. [PDF]
Hamabe L +3 more
europepmc +1 more source
The aptamer WHY‐3E identifies PrPC as a CRC driver. Stabilized by USP18, endocytosed PrPC forms a LYN/STAT3 complex, upregulating MSN transcription to promote metastasis. Crucially, WHY‐3E sensitively detects PrPC‐positive circulating exosomes, establishing a robust theoretical foundation for non‐invasive clinical diagnostics.
Chunlin Wang +23 more
wiley +1 more source
Evaluation of chest radiography and low-dose computed tomography as valuable screening tools for thoracic diseases. [PDF]
Kasuga I +8 more
europepmc +1 more source
A non‐canonical core transcriptional regulatory circuit, composed of ID3, SMAD3, and NR2F2, drives Osimertinib resistance in non‐small cell lung cancer through super‐enhancer‐mediated activation of EPAS1, which couples neuroendocrine differentiation with ferroptosis evasion.
Aochu Liu +15 more
wiley +1 more source
Artificial intelligence in thoracic diseases: the next technology to improve individual precision medicine. [PDF]
Liang H, He J.
europepmc +1 more source
SMAD4 is identified as a guardian of 3D genome architecture in lung squamous cell carcinoma. Loss of SMAD4 unleashes EP300 at chromatin loop anchors, strengthening enhancer–promoter looping and H3K27ac at the SOX2 locus to drive aberrant SOX2 activation and tumor cell proliferation.
Qian Tang +33 more
wiley +1 more source

